ProfileGDS4718 / 1570517_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 6% 5% 8% 7% 6% 7% 9% 12% 9% 5% 5% 5% 4% 6% 8% 13% 6% 2% 8% 5% 6% 2% 6% 7% 5% 3% 5% 9% 4% 6% 8% 11% 6% 5% 5% 8% 7% 10% 7% 6% 5% 6% 4% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.675317
GSM549102patient 115, normal, homogenized [OPG study]3.634116
GSM549104patient 119, normal, homogenized [OPG study]3.558055
GSM549108patient 138, normal, homogenized [OPG study]3.738438
GSM549119patient 077, normal, homogenized [OPG study]3.673267
GSM549133patient 032, cancer, homogenized [OPG study]3.596466
GSM549139patient 042, cancer, homogenized [OPG study]3.668827
GSM549099patient 107, normal, homogenized [OPG study]3.760719
GSM549109patient 139, normal, homogenized [OPG study]3.8758312
GSM549110patient 046, normal, homogenized [OPG study]3.761669
GSM549114patient 063, normal, homogenized [OPG study]3.576915
GSM549122patient 082, normal, homogenized [OPG study]3.608855
GSM549134patient 033, cancer, homogenized [OPG study]3.56625
GSM549136patient 036, cancer, homogenized [OPG study]3.511234
GSM549140patient 044, cancer, homogenized [OPG study]3.582916
GSM549111patient 047, normal, homogenized [OPG study]3.690938
GSM549113patient 057, normal, homogenized [OPG study]3.8484513
GSM549132patient 031, cancer, homogenized [OPG study]3.624936
GSM549137patient 038, cancer, homogenized [OPG study]3.438342
GSM549142patient 047, cancer, homogenized [OPG study]3.762748
GSM549100patient 110, normal, homogenized [OPG study]3.585325
GSM549107patient 135, normal, homogenized [OPG study]3.604596
GSM549115patient 068, normal, homogenized [OPG study]3.44682
GSM549116patient 072, normal, homogenized [OPG study]3.62296
GSM549120patient 078, normal, homogenized [OPG study]3.642937
GSM549131patient 030, cancer, homogenized [OPG study]3.540155
GSM549118patient 074, normal, homogenized [OPG study]3.483383
GSM549129patient 027, cancer, homogenized [OPG study]3.591715
GSM549123patient 088, normal, homogenized [OPG study]3.750589
GSM549124patient 006, cancer, homogenized [OPG study]3.558054
GSM549126patient 015, cancer, homogenized [OPG study]3.585326
GSM549128patient 025, cancer, homogenized [OPG study]3.665368
GSM549103patient 117, normal, homogenized [OPG study]3.8411711
GSM549117patient 073, normal, homogenized [OPG study]3.627276
GSM549138patient 041, cancer, homogenized [OPG study]3.545325
GSM549141patient 045, cancer, homogenized [OPG study]3.546325
GSM549130patient 028, cancer, homogenized [OPG study]3.707768
GSM549101patient 111, normal, homogenized [OPG study]3.63757
GSM549105patient 128, normal, homogenized [OPG study]3.792210
GSM549106patient 134, normal, homogenized [OPG study]3.612357
GSM549112patient 048, normal, homogenized [OPG study]3.618066
GSM549125patient 011, cancer, homogenized [OPG study]3.594325
GSM549127patient 024, cancer, homogenized [OPG study]3.620626
GSM549135patient 035, cancer, homogenized [OPG study]3.497174